selegiline has been researched along with methylphenidate in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Reimherr, FW; Wender, PH; Wood, DR | 1 |
| MacFarlane, JG; Reinish, LW; Sandor, P; Shapiro, CM | 1 |
| Riddle, MA; Scahill, LD; Walkup, JT | 1 |
| Alexoff, DL; Fowler, JS; Gatley, SJ; King, P; Schlyer, DJ; Shea, C; Wolf, AP | 1 |
| Morris, K | 1 |
| Dewey, S; Ding, YS; Fischman, MW; Foltin, R; Fowler, JS; Hitzemann, R; Volkow, ND; Wang, GJ | 1 |
| Akhondzadeh, S; Amini, H; Arabgol, F; Davari-Ashtiani, R; Tavakolian, R | 1 |
| Alaghband-Rad, J; Ghanizadeh, A; Mesgarpour, B; Mohammadi, MR; Soori, H; Tehranidoost, M | 1 |
| Levin-Epstein, M | 1 |
| Thorpy, M | 1 |
| Brown, JA; Diggs-Andrews, KA; Gutmann, DH; Mach, RH; Wozniak, DF; Xu, J | 1 |
| Canning, SD; Wang, XP; Zhang, LL | 1 |
| Osland, ST; Pringsheim, T; Steeves, TD | 1 |
| Birkenhager, TK; Caiazza, C; Cattaneo, CI; de Bartolomeis, A; Fornaro, M; Gillman, K; Iasevoli, F; Rossano, F; Ruhé, HG; Sobrino, A; Solini, N; Stahl, S; Van den Eynde, V; Vellucci, A; Zotti, N | 1 |
7 review(s) available for selegiline and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Clonidine; Comorbidity; Dextroamphetamine; Guanfacine; Humans; Learning Disabilities; Methylphenidate; Pemoline; Selegiline; Tourette Syndrome | 1995 |
Positron emission tomography studies of dopamine-enhancing drugs.
Topics: Animals; Carrier Proteins; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Selegiline; Tomography, Emission-Computed | 1999 |
Therapeutic advances in narcolepsy.
Topics: Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Humans; Immunotherapy; Methylphenidate; Modafinil; Narcolepsy; Quality of Life; Selective Serotonin Reuptake Inhibitors; Selegiline; Sodium Oxybate | 2007 |
Freezing of Gait in Parkinsonism and its Potential Drug Treatment.
Topics: Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Botulinum Toxins; Droxidopa; Gait Disorders, Neurologic; Humans; Indans; Levodopa; Methylphenidate; Middle Aged; Monoamine Oxidase Inhibitors; Parkinsonian Disorders; Selegiline; Treatment Outcome | 2016 |
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Desipramine; Dextroamphetamine; Female; Guanfacine; Humans; Male; Methylphenidate; Randomized Controlled Trials as Topic; Selegiline; Tic Disorders | 2018 |
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations.
Topics: Attention Deficit Disorder with Hyperactivity; Depressive Disorder, Major; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Selegiline | 2023 |
2 trial(s) available for selegiline and methylphenidate
| Article | Year |
|---|---|
Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.
Topics: Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Methylphenidate; Selegiline | 2003 |
Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial.
Topics: Adolescent; Anorexia Nervosa; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Female; Headache; Humans; Male; Methylphenidate; Selegiline | 2004 |
12 other study(ies) available for selegiline and methylphenidate
| Article | Year |
|---|---|
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Humans; Methylphenidate; Pargyline; Pemoline; Phenethylamines; Selegiline | 1985 |
REM changes in narcolepsy with selegiline.
Topics: Adult; Aged; Catalepsy; Female; Humans; Male; Methylphenidate; Middle Aged; Narcolepsy; Polysomnography; Retrospective Studies; Selegiline; Sleep Stages; Sleep, REM; Treatment Outcome; Wakefulness | 1995 |
Plasma input function determination for PET using a commercial laboratory robot.
Topics: Animals; Benztropine; Blood Chemical Analysis; Carbon Radioisotopes; Cocaine; Fluorobenzenes; Humans; Methylphenidate; Papio; Phenols; Radioisotopes; Reproducibility of Results; Robotics; Selegiline; Tomography, Emission-Computed | 1995 |
Seeking ways to crack cocaine addiction.
Topics: Amantadine; Clinical Trials as Topic; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Humans; Ibogaine; Methylphenidate; Selegiline | 1998 |
A new way to deliver psychiatric meds.
Topics: Administration, Cutaneous; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Selegiline; United States | 2006 |
PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Carbon Radioisotopes; Corpus Striatum; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Drug Evaluation, Preclinical; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Neurofibromatosis 1; Neuroprotective Agents; Positron-Emission Tomography; Presynaptic Terminals; Raclopride; Selegiline | 2011 |